These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy. Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837 [TBL] [Abstract][Full Text] [Related]
4. Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells. Corrêa ZM; Augsburger JJ Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):556-9. PubMed ID: 24408979 [TBL] [Abstract][Full Text] [Related]
5. Posterior uveal melanoma in young patients treated with proton beam therapy. Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates]. Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603 [TBL] [Abstract][Full Text] [Related]
7. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque. Correa ZM; Huth B; Augsburger JJ Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126 [TBL] [Abstract][Full Text] [Related]
8. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma. Mruthyunjaya P; Seider MI; Stinnett S; Schefler A; Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517 [TBL] [Abstract][Full Text] [Related]
9. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations. Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399 [TBL] [Abstract][Full Text] [Related]
10. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas. Corrêa ZM; Augsburger JJ Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399 [TBL] [Abstract][Full Text] [Related]
11. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. Lane AM; Kim IK; Gragoudas ES JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597 [TBL] [Abstract][Full Text] [Related]
12. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Kroll S; Char DH; Quivey J; Castro J Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602 [TBL] [Abstract][Full Text] [Related]
13. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy. Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after uveal melanoma charged particle therapy. Char DH; Kroll SM; Castro J Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169 [TBL] [Abstract][Full Text] [Related]
17. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747 [TBL] [Abstract][Full Text] [Related]
18. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals. Shields CL; Dalvin LA; Chang M; Mazloumi M; Fortin P; McGarrey M; Martin A; Yaghy A; Yang X; Vichitvejpaisal P; Mashayekhi A; Shields JA JAMA Ophthalmol; 2020 Feb; 138(2):136-146. PubMed ID: 31830238 [TBL] [Abstract][Full Text] [Related]
19. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928 [TBL] [Abstract][Full Text] [Related]